TCMD

+ Watchlist + Portfolio

Tactile Systems Technology, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $23.60
52-Week Range: $12.65 – $37.77
Market Cap: $530.74M
P/E (TTM): 21.90
EPS (TTM): 1.07
Dividend Yield: —

Advanced Metrics

Price/Book: 2.38
PEG Ratio: 17.79
Return on Equity: 11.88%
Return on Assets: 7.92%
Gross Margin: 76.78%
Operating Margin: 7.96%
Profit Margin: 7.10%
Current Ratio: 4.12
Debt/Equity: 0.06
Total Debt: $14.36M
Free Cash Flow: $14.47M
Revenue Growth: 8.60%
Earnings Growth: 144.10%
Enterprise Value: $475.25M

TCMD Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$246.78M	$274.42M	$292.98M	$329.52M
Cost of Revenue	$70.81M	$79.29M	$76.30M	$79.38M
Gross Profit	$175.98M	$195.13M	$216.69M	$250.15M
Research & Development	$7.09M	$7.82M	$8.83M	$8.48M
Selling, General & Admin	$167.21M	$169.19M	$183.14M	$209.94M
Operating Expenses	$188.73M	$177.09M	$194.51M	$220.87M
Operating Income	-$12.76M	$18.04M	$22.18M	$29.28M
EBITDA	$1.75M	$26.46M	$32.37M	$39.02M
Pretax Income	-$15.47M	$15.77M	$23.49M	$31.34M
Income Tax	$2.39M	-$12.74M	$6.53M	$12.25M
Net Income	-$17.87M	$28.52M	$16.96M	$19.09M
Diluted EPS	-0.89	1.23	0.70	0.82
Diluted Shares	20.07M	23.18M	24.14M	23.30M

TCMD Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$21.93M	$61.03M	$94.37M	$83.45M
Receivables	$54.83M	$43.17M	$44.94M	$43.88M
Inventory	$23.12M	$22.53M	$18.67M	$14.03M
Current Assets	$119.76M	$145.29M	$177.56M	$165.17M
Total Assets	$255.00M	$281.44M	$297.92M	$273.94M
Current Liabilities	$64.33M	$41.06M	$40.70M	$40.96M
Long-Term Debt	$45.90M	$26.18M	$23.22M	—
Total Debt	$72.23M	$50.38M	$45.11M	$15.96M
Total Liabilities	$133.60M	$87.80M	$81.33M	$55.04M
Retained Earnings	-$9.62M	$18.89M	$35.85M	$54.94M
Shareholders' Equity	$121.40M	$193.64M	$216.60M	$218.90M
Working Capital	$55.43M	$104.24M	$136.86M	$124.21M
Net Debt	$26.93M	—	—	—

TCMD Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$5.21M	$35.85M	$40.66M	$42.81M
Capital Expenditure	-$1.92M	-$2.48M	-$2.51M	-$2.54M
Free Cash Flow	$3.29M	$33.37M	$38.15M	$40.28M
Depreciation & Amortisation	$6.27M	$6.54M	$6.79M	$6.64M
Stock-Based Compensation	$9.60M	$7.55M	$7.82M	$8.36M
Investing Cash Flow	-$1.91M	-$2.48M	-$2.50M	-$2.54M
Financing Cash Flow	-$9.60M	$5.73M	-$4.82M	-$51.20M
Share Repurchases	$0.00	$0.00	-$3.51M	-$26.56M
Net Change in Cash	-$6.30M	$39.10M	$33.33M	-$10.92M

TCMD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$61.27M	$78.91M	$85.75M	$103.59M	$75.27M
Cost of Revenue	$15.92M	$20.11M	$20.75M	$22.59M	$17.65M
Gross Profit	$45.35M	$58.79M	$65.00M	$81.01M	$57.61M
Research & Development	$1.74M	$2.02M	$2.19M	$2.53M	$2.78M
Selling, General & Admin	$47.51M	$52.07M	$51.25M	$59.10M	$55.78M
Operating Expenses	$49.89M	$54.71M	$54.04M	$62.23M	$59.15M
Operating Income	-$4.54M	$4.08M	$10.96M	$18.77M	-$1.53M
EBITDA	-$1.92M	$6.59M	$13.27M	$21.08M	$771.00K
Pretax Income	-$4.07M	$4.52M	$11.44M	$19.45M	-$896.00K
Income Tax	-$1.10M	$1.31M	$3.23M	$8.81M	$867.00K
Net Income	-$2.97M	$3.22M	$8.21M	$10.63M	-$1.76M
Diluted EPS	-0.13	0.14	0.36	0.46	-0.08
Diluted Shares	23.71M	23.24M	22.51M	23.04M	22.56M

TCMD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$83.62M	$81.53M	$65.97M	$83.45M	$74.99M
Receivables	$36.89M	$33.54M	$37.26M	$43.88M	$38.22M
Inventory	$18.87M	$17.11M	$16.08M	$14.03M	$16.58M
Current Assets	$160.12M	$152.99M	$141.40M	$165.17M	$152.84M
Total Assets	$280.24M	$273.05M	$259.18M	$273.94M	$272.12M
Current Liabilities	$35.40M	$40.40M	$39.19M	$40.96M	$36.01M
Long-Term Debt	$22.48M	$21.74M	—	—	—
Total Debt	$43.65M	$42.17M	$16.73M	$15.96M	$15.17M
Total Liabilities	$74.61M	$78.12M	$54.23M	$55.04M	$54.25M
Retained Earnings	$32.88M	$36.10M	$44.31M	$54.94M	$53.18M
Shareholders' Equity	$205.63M	$194.93M	$204.95M	$218.90M	$217.87M
Working Capital	$124.72M	$112.58M	$102.21M	$124.21M	$116.83M

TCMD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$417.00K	$14.76M	$10.34M	$17.30M	-$339.00K
Capital Expenditure	-$407.00K	-$397.00K	-$1.15M	-$577.00K	-$835.00K
Free Cash Flow	$10.00K	$14.36M	$9.19M	$16.72M	-$1.17M
Depreciation & Amortisation	$1.73M	$1.66M	$1.64M	$1.62M	$1.64M
Stock-Based Compensation	$2.07M	$1.94M	$1.81M	$2.54M	$1.78M
Investing Cash Flow	-$407.00K	-$397.00K	-$1.15M	-$577.00K	-$7.06M
Financing Cash Flow	-$10.76M	-$16.45M	-$24.75M	$762.00K	-$1.05M
Share Repurchases	-$10.02M	-$16.54M	$0.00	$1.00K	-$1.07M
Net Change in Cash	-$10.75M	-$2.09M	-$15.56M	$17.48M	-$8.45M

Market Snapshot

About

Tactile Systems Technology, Inc. is a medical technology company focused on developing and marketing medical devices for the treatment of chronic diseases at home. The company specializes in pneumatic compression devices for treating lymphedema and chronic venous insufficiency.